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Introduction 
Atrial fibrillation (AF) is associated with serious complica-
tions such as atrial thrombosis and cerebral infarction com-
pared with sinus rhythm (SR).1) Left atrial appendage (LAA) 
dysfunction is known as a significant predictor of thrombus 
formation.2)3) LAA anatomy and function have been well char-
acterized both in patients with AF and with SR,4-6) whereas 
little attention has been focused on the right atrial appendage 
(RAA).
Recently, RAA thrombi7-10) and RAA function11) have been 
reported in patients with AF. Bilge et al.12) suggested that 
RAA function is also decreased in patients with AF compared 
to those with SR.
Therefore, we hypothesized that RAA dysfunction is associ-
ated with left ventricular dysfunction as is LAA dysfunction. 
In this study, RAA flow velocity and LAA flow velocity were 
compared among patients with AF and SR. We found that 
RAA flow velocity correlates with LAA flow velocity, and that 
RAA velocity correlates with the concentration of brain natri-
uretic peptide (BNP), a biochemical marker of left ventricular 
dysfunction.
Methods
Study population  
Seventy-nine patients referred for transesophageal echocar-
diography were evaluated in our study from April to July 2008. 
Of these patients, we excluded those with valvular heart disease, 
malignancy, or severe congestive heart failure. A total of 43 pa-
tients including 23 AF patients and 20 control patients were 
pISSN 1975-4612/ eISSN 2005-9655 
Copyright © 2012 Korean Society of Echocardiography 
www.kse-jcu.org http://dx.doi.org/10.4250/jcu.2012.20.1.37
ORIGINAL ARTICLE J Cardiovasc Ultrasound  2012;20(1):37-41
Correlation of Right Atrial Appendage 
Velocity with Left Atrial Appendage 
Velocity and Brain Natriuretic Peptide
Bu-Kyung Kim, MD1, Jung-Ho Heo, MD1, Jae-Woo Lee, MD, PhD1, Hyun-Soo Kim, MD1, 
Byung-Joo Choi, MD2 and Tae-Joon Cha, MD, PhD1
1Division of Cardiology, Department of Internal Medicine, Kosin University School of Medicine, Busan, Korea
2Division of Cardiology, Department of Internal Medicine, Ulsan Hospital, Ulsan, Korea
Background: Left atrial appendage (LAA) anatomy and function have been well characterized both in healthy and diseased 
people, whereas relatively little attention has been focused on the right atrial appendage (RAA). We sought to evaluate RAA flow 
velocity and to compare these parameters with LAA indices and with a study of biomarkers, such as brain natriuretic peptide, 
among patients with sinus rhythm (SR) and atrial fibrillation (AF).
Methods: In a series of 79 consecutive patients referred for transesophageal echocardiography, 43 patients (23 with AF and 20 
controls) were evaluated. 
Results: AF was associated with a decrease in flow velocity for both LAA and RAA [LAA velocity-SR vs. AF: 61 ± 22 vs. 29 
± 18 m/sec (p < 0.01), RAA velocity-SR vs. AF: 46 ± 20 vs. 19 ± 8 m/sec (p < 0.01)]. Based on simple linear regression analysis, 
LAA velocity and RAA velocity were positively correlated, and RAA velocity was inversely correlated with brain natriuretic 
peptide (BNP).
Conclusion: AF was associated with decreased RAA and LAA flow velocities. RAA velocity was found to be positively 
correlated with LAA velocity and negatively correlated with BNP. The plasma BNP concentration may serve as a determinant of 
LAA and RAA functions.
KEY WORDS: Atrial appendage · Atrial function · Brain natriuretic peptide.
•	Received: November 17, 2011  •	Revised: February 16, 2012  •	Accepted: February 17, 2012   
•	Address for Correspondence: Tae-Joon Cha, Division of Cardiology, Department of Internal Medicine, Kosin University School of Medicine, 262 Gamcheon-ro, 
Seo-gu, Busan 602-702, Korea      Tel: +82-51-990-6105, Fax: +82-51-990-3047, E-mail: chatjn@hananet.net
•	This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  
  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Cardiovascular Ultrasound 20 | March  2012
38
enrolled in our study. Baseline clinical characteristics included 
age, sex, height, weight, smoking history, and the statuses of 
various medical conditions including systemic hypertension, di-
abetes, and hyperlipidemia. We defined hyperlipidemia as a tri-
glyceride level greater than 200 mg/dL or an low-density lipo-
protein level greater than 130 mg/dL.
Approval was granted by the institutional review board, 
and patients were required to provide informed consent.
Echocardiography
All patients underwent both transthoracic and multiplane 
transesophageal echocardiography.
The studies were performed with a 3.25-MHz transthorac-
ic transducer (Philips Medical Systems, Andover, MA, USA) 
with patients in the left lateral decubitus position. Transtho-
racic echocardiography studies were carried out according to 
the recommendations of the American Society of Echocar-
diography.13) M-mode left atrial (LA) dimension, right ven-
tricular (RV) dimension, and interventricular septal dimen-
sion were measured in the parasternal long-axis view at end-
diastole. Left ventricular end diastolic dimension, left ventricular 
end systolic dimension, and ejection fraction were measured 
in the parasternal long-axis view. Tissue velocities (E and e’) 
were measured at septum in Doppler images, and E/e’ was 
calculated. RV systolic pressure was calculated using the RV-
right atrial pressure gradient and tricuspid regurgitation ve-
locity.14)
Transesophageal echocardiography was performed using a 
commercial 2-7-MHz multiplane probe (Philips Medical Sys-
tems, Andover, MA, USA) after patient fasting. Topical lido-
caine spray and viscous lidocaine solution were used to anes-
thetize the oropharynx before the investigation. The LAA was 
imaged in the basal short-axis view using a transverse scan 
from 0 to 45 degrees (Fig. 1). The scanning plane was rotated 
from 90 to 145 degrees to achieve visualization of the RAA 
(Fig. 2).15) Peak LAA and RAA ejection and filling velocities 
were measured by placing a pulsed wave Doppler sample vol-
ume just inside the base of the appendage, as suggested by 
Fatkin et al.4)
Laboratory measurements
All blood samples were obtained the day after hospital ad-
mission and before transesophageal echocardiogram (TEE). 
The plasma BNP and high-sensitivity C-reactive protein (hs-
CRP) concentrations were measured with an ACCESS 2 pro-
duced by Beckman Coulter and an LX20 produced by Beck-
man Coulter (Brea, CA, USA), respectively.
Statistics
Values are expressed as mean ± SD. Continuous variables 
between groups were compared using student’s t-test. Normi-
nal variables between groups were compared using Chi-square 
test. Correlations between RAA velocities and LAA velocities 
and between RAA velocities and BNP were performed with a 
pearson’s correlation analysis (version 12.0 for Windows; SPSS, 
Chicago, IL, USA).
Results
Patient characteristics
The clinical characteristics for all 43 patients (mean age 
64.1 ± 14.3 years), including the AF group and SR group, are 
shown in Table 1. There were no statistically significant differ-
ences in height, weight, or body surface area level between the 
AF group and SR group. Hypertension, diabetes mellitus, 
smoking, and hyperlipidemia were more frequently seen in 
the AF group than they were in the SR group.
Echocardiography
The transthoracic echocardiographic (TTE) parameters are 
listed in Table 2. LA size was significantly larger among pa-
tients in the AF group than in the SR group [AF vs. SR: 4.6 
± 0.65 vs. 3.5 ± 0.78 cm (p = 0.00)]. The E/e’ value was greater 
in the AF group [AF vs. SR: 9.35 ± 3.51 vs. 7.35 ± 2.97 (p = 
Fig. 1. Left atrial appendage and peak velocity. Fig. 2. Right atrial appendage and peak velocity.Right Atrial Appendage Velocity | Bu-Kyung Kim, et al.
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0.059)], but it was not statistically significant. Significant dif-
ferences were not seen for any other measurements.
LAA and RAA velocities according to TEE were all signifi-
cantly slower in the AF group compared to those in the SR 
group (Table 3). The mean LAA ejection velocity (LAA E) was 
29 ± 18 cm/sec in the AF group and 61 ± 22 cm/sec in the SR 
group (p < 0.001), and the mean LAA filling velocity (LAA F) 
was 33 ± 18 m/sec in the AF group and 58 ± 29 m/sec in the 
SR group (p < 0.001). The mean RAA ejection velocity (RAA 
e) and filling velocity (RAA f) were also slower in the AF group 
than in the SR group [AF vs. SR: 19 ± 8 vs. 46 ± 20 cm/sec (p 
< 0.001), 22 ± 0.12 vs. 39 ± 13 cm/sec (p < 0.001)].
Biochemical markers
There was no statistically significant difference in hs-CRP 
concentration between the two groups, but the BNP level was 
higher in the AF group than in the SR group [AF vs. SR: 301.4 
± 286.6 vs. 107.2 ± 158.3 pg/mol (p = 0.016)] (Table 4).
Correlations
BNP concentration was negatively correlated with LAA 
emptying velocity (r = -0.44; p = 0.01) and with LAA filling 
velocity (r = -0.39; p = 0.01). BNP expression was also nega-
tively correlated with RAA emptying velocity (r = -0.36; p = 
0.02) and with RAA filling velocity (r = -0.34; p = 0.03) (Table 
5). RAA velocities and LAA velocities were significantly posi-
Table 1. Baseline characteristics between SR and AF groups were compared using t-test and Chi-square test
Total patients  (n = 43) AF (n = 23) SR (n = 20) p value
Age (yr)     64.1 ± 14.3      64.4 ± 14.6       62.5 ± 17.7 0.318
Sex (M/F) 25/18 18/5 7/13 0.012
Height (cm) 166.73 ± 8.39 167.68 ± 7.9 165.63 ± 8.9 0.067
Weight (kg)     66.66 ± 16.34       69.59 ± 10.59       63.26 ± 20.97 0.116
BSA (m
2)   23.75 ± 4.25     24.65 ± 2.76     21.47 ± 6.85 0.191
Hypertension (Yes/No)   8/35     7/16 1/19 0.037
Diabetes (Yes/No)   3/39      3/20 1/19 0.359
Smoking (Yes/No) 18/25   13/10 5/15 0.037
Hyperlipidemia (Yes/No) 11/32     8/15 3/17 0.128
AF: atrial fibrillation, SR: sinus rhythm, BSA: body surface area
Table 2. Comparison of transthoracic echocardiographic parameters in patients with AF and SR
AF (n = 23) SR (n = 20) p value
Aorta (cm)   3.34 ± 0.49   3.22 ± 0.63 0.506
LA (cm)   4.60 ± 0.65   3.50 ± 0.78 0.000
RV (cm)   2.49 ± 0.43   2.31 ± 0.87 0.380
IVS (cm)   1.25 ± 0.30   1.12 ± 0.28 0.145
LVED (cm)   4.92 ± 0.74   4.57 ± 0.96 0.180
LVES (cm)   3.26 ± 0.79   2.95 ± 0.69 0.188
EF (%)   62.03 ± 13.08 65.05 ± 6.82  0.360
E (cm/sec)   81.79 ± 25.04   72.78 ± 37.65 0.362
e' (cm/sec)   9.22 ± 2.08   9.53 ± 3.06 0.710
E/e'   9.35 ± 3.51   7.35 ± 2.97 0.059
RVSP 29.9 ± 8.4   30.8 ± 10.6 0.758
AF: atrial fibrillation, SR: sinus rhythm, LA: left atrium, RV: right ventricle, IVS: interventricular septum, LVED: left ventricular end diastolic, LVES: left 
ventricular end systolic, EF: ejection fraction, RVSP: right ventricular systolic pressure
Table 3. Comparison of appendage velocity in patients with AF and 
SR (transesophageal echocardiographic assessment)
AF (n = 23) SR (n = 20) p value
LAA E* (cm/sec) 29 ± 18 61 ± 22 < 0.001
LAA F† (cm/sec) 33 ± 18 58 ± 19 < 0.001
RAA e* (cm/sec) 19 ± 8 46 ± 20 < 0.001
RAA f† (cm/sec) 22 ± 12 39 ± 13 < 0.001
*Peak emptying velocity, †Peak filling velocity. AF: atrial fibrillation, SR: 
sinus rhythm, LAA: left atrial appendage, RAA: right atrial appendage
Table 4. Comparison of biochemical markers in patients with AF 
and SR
AF (n = 23) SR (n = 20) p value
BNP (pg/mL) 301.4 ± 286.6 107.2 ± 158.3 0.016
  hs-CRP (mg/L) 0.74 ± 0.83 1.7 ± 3.7 0.238
AF: atrial fibrillation, SR: sinus rhythm, BNP: brain natriuretic peptide, 
CRP: C-reactive proteinJournal of Cardiovascular Ultrasound 20 | March  2012
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tively correlated with each other (r = 0.53; p = 0.0, r = 0.5; p = 
0.0, r = 0.62; p = 0.0, r = 0.61; p = 0.0).
Discussion
Evaluation of the LAA using transesophageal echocardiog-
raphy of AF is a standard procedure in patients who are in fi-
brillation. In 2-D imaging, potential thrombus and spontane-
ous echo contrast should be analyzed. A pulsed Doppler TEE 
analysis of LAA emptying flow should be conducted to sup-
plement the 2-D analysis as these examinations have been 
shown to be highly reproducible and to help assess thrombo-
embolic risk.16)
Mikael Kortz et al.17) found that the LAA blood flow pat-
tern in healthy subjects was variable, changing from quadri- 
to tri- and biphasic with increasing heart rate. In another 
study, a similar relationship was also observed for the RAA.
When heart failure or hypertension occurs, one of the most 
important forms of remodeling is an increase in muscle mass 
in response to a pressure or volume overload or myocardial in-
jury.18) In cases of ventricular remodeling, both enlargement of 
the myocytes and interstitial or perivascular fibrosis are ob-
served simultaneously.
The peripheral plasma BNP concentration can be used as a 
biochemical marker of left ventricular dysfunction. This pro-
tein increases not only in patients with systolic dysfunction, 
such as in dilated cardiomyopathy, but also in patients with 
hypertension or hypertrophic cardiomyopathy, of which usual-
ly not involve systolic dysfunction. The plasma BNP concen-
tration increases in proportion to the degree of left ventricular 
end-systolic stress and end-diastolic pressure. Patients with 
AF showed an inverse correlation between BNP concentration 
and LAA flow velocity.3)
There are few studies about the RAA, most likely because 
of its location and clinical importance. The RAA is a cardiac 
structure that is difficult to examine using TTE. However, 
TEE is a good tool to evaluate RAA. In 1999, Bilge et al.19) 
analyzed RAA blood flow patterns in normal subjects without 
cardiovascular disease using TEE, resulting in the first study 
on RAA. Since then, several studies on RAA anatomy and 
RAA function and its implications for thrombus formation 
have been reported.12)20)21)
In our study, we were able to easily examine RAA function 
and anatomy using TEE, especially peak emptying velocity 
and peak filling velocity. LAA and RAA peak emptying and 
filling velocities were lower in the AF group compared with 
those in the control group. These results suggest that AF leads 
to decrease not only in LA function but also in RA function. 
The larger E/e’ in the AF group indicates that AF group has 
worse LV diastolic dysfunction than SR group.
BNP concentration is known to be associated with LA 
function.22) In our study, BNP level was correlated with LAA 
and RAA velocity (emptying and filling). BNP concentration 
may therefore correlate with RAA function.
There were several limitations to this study. First, we did 
not observe significant correlations between variables in pa-
tients with AF. This lack of significance may be associated 
with small size of the study group. Second, no hemodynamic 
parameters like right atrial pressure or right atrial volume were 
included in the analysis. Third, we could not exclude all possi-
ble heart problems which may have affected the SRs of 
patients used as a control group. Despite these limitations, the 
results of this study will serve as a very useful reference for fu-
ture studies about RAA anatomy and function.
In conclusion, AF is associated with depressed RAA and 
LAA flow velocities and with increased LA size. RAA velocity 
was found to be positively correlated with LAA velocity and 
negatively correlated with BNP concentration. Therefore, plas-
ma BNP concentration may serve as a determinant of LAA 
and RAA functions. Further study is required to determine 
the clinical significance of RAA.
References
1. Petersen P. Thromboembolic complications in atrial fibrillation. Stroke 
1990;21:4-13.
2. Caplan LR, D’Cruz I, Hier DB, Reddy H, Shah S. Atrial size, atrial 
fibrillation, and stroke. Ann Neurol 1986;19:158-61.
3. Igarashi Y, Kashimura K, Makiyama Y, Sato T, Ojima K, Aizawa Y. 
Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation 
is significantly associated with an elevated level of brain natriuretic peptide 
and a prothrombotic state. Jpn Circ J 2001;65:788-92.
4. Fatkin D, Kelly RP, Feneley MP. Relations between left atrial append-
age blood flow velocity, spontaneous echocardiographic contrast and thrombo-
embolic risk in vivo. J Am Coll Cardiol 1994;23:961-9.
5. Grimm RA, Stewart WJ, Maloney JD, Cohen GI, Pearce GL, Sal-
cedo EE, Klein AL. Impact of electrical cardioversion for atrial fibrillation 
on left atrial appendage function and spontaneous echo contrast: character-
ization by simultaneous transesophageal echocardiography. J Am Coll Car-
diol 1993;22:1359-66.
6. Zeppellini R, Schön F, Gheno G, Drozdz J, Balzereit A, Cucchini F, 
Erbel R. Left atrial appendage systolic forward flow. Am J Cardiol 1995; 
75:204-6.
7. Klein AL, Grimm RA, Jasper SE, Murray RD, Apperson-Hansen C, 
Lieber EA, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli 
DA, Porter TR, Stoddard MF; ACUTE Steering and Publications 
Committee for the ACUTE Investigators. Efficacy of transesophageal 
echocardiography-guided cardioversion of patients with atrial fibrillation at 
6 months: a randomized controlled trial. Am Heart J 2006;151:380-9.
8. Manning WJ, Silverman DI, Gordon SP, Krumholz HM, Douglas 
PS. Cardioversion from atrial fibrillation without prolonged anticoagula-
tion with use of transesophageal echocardiography to exclude the presence of 
Table 5. Correlations between BNP concentration and atrial ap-
pendage velocities
R p value
LAA E -0.44 0.01
LAA F -0.39 0.01
RAA e -0.36 0.02
RAA f -0.34   0.03
LAA: left atrial appendage, RAA: right atrial appendageRight Atrial Appendage Velocity | Bu-Kyung Kim, et al.
41
atrial thrombi. N Engl J Med 1993;328:750-5.
9. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. 
Transesophageal echocardiographically facilitated early cardioversion from 
atrial fibrillation using short-term anticoagulation: final results of a pro-
spective 4.5-year study. J Am Coll Cardiol 1995;25:1354-61.
10. Stoddard MF, Dawkins PR, Prince CR, Longaker RA. Transesopha-
geal echocardiographic guidance of cardioversion in patients with atrial fi-
brillation. Am Heart J 1995;129:1204-15.
11. Omran H, Jung W, MacCarter D, Schimpf R, Rabahieh R, Schum-
acher B, Wolpert C, Becher H, Lüderitz B. Right atrial thrombi and 
depressed right atrial appendage function after cardioversion of atrial fibril-
lation. Echocardiography 1999;16:245-51.
12. Bilge M, Eryonucu B, Güler N, Erkoç R. Right atrial appendage 
function in patients with chronic nonvalvular atrial fibrillation. Jpn Heart 
J 2000;41:451-62.
13. Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp 
RL, Sahn DJ, Schiller NB, Tajik A, Teichholz LE, Weyman AE. Re-
port of the American Society of Echocardiography Committee on Nomencla-
ture and Standards in Two-dimensional Echocardiography. Circulation 
1980;62:212-7.
14. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic 
pressure by Doppler ultrasound in patients with tricuspid regurgitation. 
Circulation 1984;70:657-62.
15. Seward JB, Khandheria BK, Freeman WK, Oh JK, Enriquez-Sara-
no M, Miller FA, Edwards WD, Tajik AJ. Multiplane transesophageal 
echocardiography: image orientation, examination technique, anatomic corre-
lations, and clinical applications. Mayo Clin Proc 1993;68:523-51.
16. Donal E, Yamada H, Leclercq C, Herpin D. The left atrial appendage, 
a small, blind-ended structure: a review of its echocardiographic evaluation 
and its clinical role. Chest 2005;128:1853-62.
17. Mikael Kortz RA, Delemarre BJ, van Dantzig JM, Bot H, Kamp O, 
Visser CA. Left atrial appendage blood flow determined by transesophageal 
echocardiography in healthy subjects. Am J Cardiol 1993;71:976-81.
18. Titcomb CP Jr. LVH: consequences associated with cardiac remodeling. J 
Insur Med 2004;36:42-6.
19. Bilge M, Eryonucu B, Güler N, Aşker M. Evaluation of right atrial 
appendage blood flow by transesophageal echocardiography in subjects with a 
normal heart. Jpn Heart J 1999;40:599-607.
20. de Divitiis M, Omran H, Rabahieh R, Rang B, Illien S, Schimpf R, 
MacCarter D, Jung W, Becher H, Lüderitz B. Right atrial appendage 
thrombosis in atrial fibrillation: its frequency and its clinical predictors. Am 
J Cardiol 1999;84:1023-8.
21. Subramaniam B, Riley MF, Panzica PJ, Manning WJ. Transesopha-
geal echocardiographic assessment of right atrial appendage anatomy and 
function: comparison with the left atrial appendage and implications for lo-
cal thrombus formation. J Am Soc Echocardiogr 2006;19:429-33.
22. Tabata T, Oki T, Yamada H, Abe M, Onose Y, Thomas JD. Rela-
tionship between left atrial appendage function and plasma concentration of 
atrial natriuretic peptide. Eur J Echocardiogr 2000;1:130-7.